| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.956 | 10.154 | 13.456 | 10.761 | 10.772 | 6.994 | 5.541 | 8.845 | 10.777 | 16.456 |
| Total Income - EUR | 1.956 | 10.155 | 13.456 | 10.762 | 10.772 | 6.996 | 5.541 | 8.845 | 10.777 | 16.456 |
| Total Expenses - EUR | 5.054 | 6.724 | 6.756 | 6.393 | 8.326 | 7.540 | 7.538 | 8.005 | 10.937 | 14.201 |
| Gross Profit/Loss - EUR | -3.098 | 3.430 | 6.701 | 4.369 | 2.446 | -545 | -1.997 | 840 | -160 | 2.255 |
| Net Profit/Loss - EUR | -3.156 | 3.227 | 6.566 | 4.261 | 2.338 | -615 | -2.053 | 751 | -268 | 1.762 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 1 |
Check the financial reports for the company - Ilmad-Centrul Medical Antistres Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 18 | 20 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.890 | 2.779 | 4.148 | 4.999 | 7.391 | 235 | 385 | 1.184 | 2.871 | 1.055 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 752 | 1.233 | 1.400 | 889 | 5.753 | 1 | 110 | 549 | 2.000 | 0 |
| Cash | 1.138 | 1.546 | 2.748 | 4.110 | 1.638 | 234 | 275 | 634 | 871 | 1.055 |
| Shareholders Funds | -8.199 | -4.889 | 1.760 | 4.519 | 6.770 | -367 | -2.411 | -1.668 | -1.930 | -158 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 10.089 | 7.667 | 2.388 | 498 | 641 | 602 | 2.797 | 2.852 | 4.801 | 1.213 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ilmad-Centrul Medical Antistres Srl